Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: A pilot study of 21 patients

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 5, 2006, Pages 412-418

  Hasegawa, Midori ^a   Ohashi, Atsushi ^b   Kabutan, Nao ^c   Hiramatsu, Saori ^c   Kato, Masao ^c   Murakami, Kazutaka ^a   Tomita, Makoto ^a   Nabeshima, Kunihiro ^a   Hiki, Yoshiyuki ^a   Sugiyama, Satoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cytapheresis; Myeloperoxidase antineutrophil cytoplasmic autoantibody associated vasculitis; Prognosis

Indexed keywords

CORTICOSTEROID; CREATININE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ABDOMINAL PAIN; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTAPHERESIS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; KIDNEY FUNCTION; LUNG HEMORRHAGE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CREATININE; CYTAPHERESIS; FEMALE; HEMORRHAGE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LUNG DISEASES; MALE; MIDDLE AGED; PEROXIDASE; PILOT PROJECTS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; VASCULITIS;

EID: 33750442906     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00404.x     Document Type: Article

References (14)

1. Kamesh L, Harpper L, Savage COS. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60.
2. NowackR, GobeIU, KlookerP et al. Mycophenolate mofetil for maintenance therapy of Wegeners granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-71.
3. Jayne TRW, Chapel H, Adu D et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJMed 2000;93:433-9.
4. StoneJ, UhlfelderM, HellmannD, CrooksS, Bedocs N, Hoffman G. Etanercept combined with conventional treatment in Wegeners granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 2001;44:1149-54.
5. SchmittWH, Hagen CH, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ. Treatment of refractory Wegeners granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004;65:1440-8.
6. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84.
7. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004;19:1403-11.
8. Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A. Clinical prognostic factor of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA) -associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 2003;18:v5-v7.
9. Gallagher H, Kwan JTC, Jayne DRW. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002;39:42-7.
10. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
11. Hasegawa M, Kawamura N, Kasugai M et al. Cytaphresis for the treatmentof myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Report of five cases. Ther Apher Dial 2002;6:443-9.
12. HasegawaM, WatanabeA, Takahashi H et al. Treatment of cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors. Ther Apher Dial 2005;9:297-302.
13. Hanai H, Iida T, Takeuchi K et al. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 2005;28:3085-90.
14. KashiwagiN, Sugimura K, Koiwai H et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as atreatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334-41.